In particular, in contrast with PV-FP and PV-O subtype, PV-T glioblastomas were characterized by a high expression of the mesenchymal marker VEGFC and the proneural and CSC markers NOTCH1 and PROM1 that could be potential targets for specific therapies. The gene discussed is PROM1; the disease is glioblastoma.